| 2019-02-19 |
17 |
|
1402
Patents-in-Suit in twelve separate counts, as follows: United States Patent Nos. 7,758,891 (891
…Tithe of Patent : _?) “Glanmed Use 0°:
I fF 28-36: Ex A 7,758,891 | “Combinations and modes of | “A method…891
patent,” Count I; 7,820,788 (788 patent,” Count ID), 7,923,536 ¢°536 patent,” Count UD),
8,034,375 (… (°375 patent,” Count IV), 8,138,229 (229 patent,” Count V), 8,268,348 (348
patent,” Count V1), 8,314,…8,314,156 (° 156 patent,” Count VII), 8,853,260 (°°260 patent,” Count VII),
9,101,543 (543 patent,” Count IX |
External link to document |
| 2019-05-28 |
36 |
Order - -Memorandum and Order |
The patents-in-suit include United States Patent Nos. 7,758,891 ("the '891 patent"),…in a patent or the
use of which is claimed in a patent before the expiration of such patent.
…infringement of twelve patents under 35
U.S.C. § 271(e). (D.I. 1). The patents-in-suit 1 relate to various… ("the '788 patent"),
7,923,536 (''the '536 patent"), 8,034,375 ("…"the '375 patent"), 8,138,229 ("the '229 patent"), 8,268,348 ('' |
External link to document |
| 2018-12-19 |
4 |
|
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,758,891 B2 ;7,820,788 B2 ;7,923,536…
11 February 2020
1:18-cv-02019
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
